PenderFund Capital Management Ltd.

13F Portfolio Filings

Most recent 13F
Q2 2024
Location
Vancouver, British Columbia
CIK
0001706164
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q2 2024 126 363,886 ESPERION THERAPEUTICS INC NE, FIRST MAJESTIC SILVER CORP, BANDWIDTH INC, SSR MINING IN 13F-HR 8/14/2024 000170616424000003
Q1 2024 116 378,180 ESPERION THERAPEUTICS INC NE, FIRST MAJESTIC SILVER CORP, BANDWIDTH INC, SSR MINING IN 13F-HR 5/15/2024 000170616424000002
Q4 2023 105 306,776 ESPERION THERAPEUTICS INC NE, FIRST MAJESTIC SILVER CORP, SSR MINING IN, OPKO HEALTH INC 13F-HR 2/14/2024 000170616424000001
Q3 2023 112 333,695 ESPERION THERAPEUTICS INC NE, FIRST MAJESTIC SILVER CORP, OPKO HEALTH INC, BANDWIDTH INC 13F-HR 11/14/2023 000170616423000004
Q2 2023 114 321,680 BANDWIDTH INC, ESPERION THERAPEUTICS INC NE, OPKO HEALTH INC, FIRST MAJESTIC SILVER CORP 13F-HR 8/10/2023 000170616423000003
Q1 2023 130 318,441 FIRST MAJESTIC SILVER CORP, OPKO HEALTH INC, PARATEK PHARMACEUTICALS INC, BANDWIDTH INC 13F-HR 5/15/2023 000170616423000002
Q4 2022 140 335,435 FORUM ENERGY TECHNOLOGIES IN, PARATEK PHARMACEUTICALS INC, OPKO HEALTH INC, ESPERION THERAPEUTICS INC NE 13F-HR 2/10/2023 000170616423000001
Q3 2022 179 319,685 ESPERION THERAPEUTICS INC NE, FORUM ENERGY TECHNOLOGIES IN, PARATEK PHARMACEUTICALS INC, OPKO HEALTH INC 13F-HR 11/14/2022 000170616422000004
Q2 2022 179 361,688 ESPERION THERAPEUTICS INC NE, FORUM ENERGY TECHNOLOGIES IN, PRECIGEN INC, PARATEK PHARMACEUTICALS INC 13F-HR 8/15/2022 000170616422000003
Q1 2022 172 408,318 SANGOMA TECHNOLOGIES CORP, PARATEK PHARMACEUTICALS INC, PRECIGEN INC, ESPERION THERAPEUTICS INC NE 13F-HR 5/17/2022 000170616422000002
Q4 2021 157 440,535 SANGOMA TECHNOLOGIES CORP COM, PARATEK PHARMACEUTICALS INC, PRECIGEN INC, SFIX 13F-HR 2/15/2022 000170616422000001
Q3 2021 140 382,691 PARATEK PHARMACEUTICALS INC, BUR.L, INTREXON CORP, TRICIDA INC 13F-HR 11/15/2021 000170616421000006
Q2 2021 88 427,168 PARATEK PHARMACEUTICALS INC, BUR.L, INTERCEPT PHARMACEUTICALS IN, Z 13F-HR 8/13/2021 000170616421000005
Q1 2021 92 411,798 PARATEK PHARMACEUTICALS INC, BUR.L, INTERCEPT PHARMACEUTICALS IN, SSNC 13F-HR 5/10/2021 000170616421000004
Q4 2020 81 393,371 PARATEK PHARMACEUTICALS INC, FIRST MAJESTIC SILVER CORP, BUR.L, BIDU 13F-HR 2/12/2021 000170616421000003
Q3 2020 70 359,603 SUNPOWER CORP, PARATEK PHARMACEUTICALS INC, JENGQ, TWITTER INC 13F-HR 11/16/2020 000170616420000004
Q2 2020 71 369,964 SUNPOWER CORP, PARATEK PHARMACEUTICALS INC, EGAN, TWITTER INC 13F-HR 8/17/2020 000170616420000003
Q1 2020 57 320,386 SUNPOWER CORP, TWITTER INC, PARATEK PHARMACEUTICALS INC, AVAYA HLDGS CORP 13F-HR 4/27/2020 000170616420000002
Q4 2019 55 356,325 SUNPOWER CORP, SSNC, HHC, KKR 13F-HR 2/5/2020 000170616420000001
Q3 2019 64 297,251 SUNPOWER CORP, AVAYA HLDGS CORP, KKR, SSNC 13F-HR 10/29/2019 000170616419000007
Q2 2019 67 280,132 KKR, HHC, SUNPOWER CORP, SSNC RESTATEMENT 7/31/2019 000170616419000005
Q1 2019 69 343,893 SUNPOWER CORP, KKR, HHC, SSNC 13F-HR 4/23/2019 000170616419000002
Q4 2018 70 302,439 MIDD, ESI, KKR, SSNC 13F-HR 1/24/2019 000170616419000001
Q3 2018 69 322,057 BIDU, HHC, LILA, CFX 13F-HR 10/17/2018 000170616418000005
Q2 2018 63 285,980 BIDU, ESI, HHC, SW.TO 13F-HR 7/17/2018 000170616418000004
Q1 2018 71 240,142 KW, ESI, SW.TO, HHC 13F-HR 5/4/2018 000170616418000002
Q4 2017 35 152,406 BIDU, LILA, TRIP, CFX 13F-HR 2/6/2018 000170616418000001
Additional filings from PenderFund Capital Management Ltd. that have since been restated